Privi Speciality Chemicals Limited Board Approves Q3 FY26 Results and ₹50 Crore Equity Infusion in Subsidiary
Privi Speciality Chemicals Limited announced the outcome of its Board meeting held on February 09, 2026, approving the Unaudited Financial…